What We Know About Obamacare, Part I

Obamacare’s third open enrollment season kicked off yesterday, beginning the next chapter in its turbulent history.  Today’s post discusses what we know about Obamacare.  Tomorrow’s will discuss what we don’t yet know.

<a class=”button” title=”Read More” href=”What We Know About Obamacare, Part I”>Read More</a>

RSSHealth Policy Matters.
RSS Recent Galen Commentary.
RSS The Round Up.

Using Better Data to Produce Better Patient Outcomes
November 20, 2015

By Grace-Marie Turner The next big challenge in the pharmaceutical sector is not going to be producing breakthrough treatments for once-deadly illnesses.  The industry is on track to accomplish that with 3,400 medicines in development today in the United States…

The Galen Institute, Inc., is a not-for-profit, free-market research organization devoted exclusively to health policy. It was founded in 1995 by Grace-Marie Turner to promote a more informed public debate over individual freedom, consumer choice, competition, and diversity in the health sector.

© Galen Institute; All Rights Reserved